Article in Radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06906042 (Multimodal Cardiovascular and Hepatic Population Imaging), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
NCT06906042 recruitingnot on this mapstarted 2025, after this paper: background citation
Multimodal Cardiovascular and Hepatic Population Imaging
Typeobservational_patient_registrySponsorInstitut National de la Santé Et de la Recherche Médicale, FranceRan2025 to 2033Enrolled2,400ConditionsHealthy Volunteers, Imaging EvaluationArmsImaging examinations, Paramedical examinations, Medical examination, Echocardiography
3 · Its place in the literature
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors at 2 institutions in 3 countries.
Charlène A Mauger *From the Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand (C.A.M.); Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand (C.A.M., K.G.); Department of Biomedical Engineering, King's College London, London, UK (A.S., A.A.Y.); Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wis (D.A.B.); and Department of Cardiology, Johns Hopkins Medical Center, Baltimore, Md (C.O.W., J.A.C.L., B.A.V.).ORCID 0000-0003-1613-2668
Kathleen Gilbert *From the Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand (C.A.M.); Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand (C.A.M., K.G.); Department of Biomedical Engineering, King's College London, London, UK (A.S., A.A.Y.); Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wis (D.A.B.); and Department of Cardiology, Johns Hopkins Medical Center, Baltimore, Md (C.O.W., J.A.C.L., B.A.V.).
Avan SuinesiaputraFrom the Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand (C.A.M.); Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand (C.A.M., K.G.); Department of Biomedical Engineering, King's College London, London, UK (A.S., A.A.Y.); Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wis (D.A.B.); and Department of Cardiology, Johns Hopkins Medical Center, Baltimore, Md (C.O.W., J.A.C.L., B.A.V.).
David A BluemkeFrom the Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand (C.A.M.); Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand (C.A.M., K.G.); Department of Biomedical Engineering, King's College London, London, UK (A.S., A.A.Y.); Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wis (D.A.B.); and Department of Cardiology, Johns Hopkins Medical Center, Baltimore, Md (C.O.W., J.A.C.L., B.A.V.).ORCID 0000-0002-8323-8086
Colin O WuFrom the Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand (C.A.M.); Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand (C.A.M., K.G.); Department of Biomedical Engineering, King's College London, London, UK (A.S., A.A.Y.); Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wis (D.A.B.); and Department of Cardiology, Johns Hopkins Medical Center, Baltimore, Md (C.O.W., J.A.C.L., B.A.V.).ORCID 0000-0002-4514-0926
João A C LimaFrom the Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand (C.A.M.); Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand (C.A.M., K.G.); Department of Biomedical Engineering, King's College London, London, UK (A.S., A.A.Y.); Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wis (D.A.B.); and Department of Cardiology, Johns Hopkins Medical Center, Baltimore, Md (C.O.W., J.A.C.L., B.A.V.).ORCID 0000-0001-8756-6995
Alistair A YoungFrom the Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand (C.A.M.); Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand (C.A.M., K.G.); Department of Biomedical Engineering, King's College London, London, UK (A.S., A.A.Y.); Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wis (D.A.B.); and Department of Cardiology, Johns Hopkins Medical Center, Baltimore, Md (C.O.W., J.A.C.L., B.A.V.).ORCID 0000-0001-5702-4220
Bharath Ambale-VenkateshFrom the Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand (C.A.M.); Auckland Bioengineering Institute, University of Auckland, Auckland, New Zealand (C.A.M., K.G.); Department of Biomedical Engineering, King's College London, London, UK (A.S., A.A.Y.); Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wis (D.A.B.); and Department of Cardiology, Johns Hopkins Medical Center, Baltimore, Md (C.O.W., J.A.C.L., B.A.V.).ORCID 0000-0002-2330-2373
Johns Hopkins University · USUniversity of Wisconsin–Madison · US
Funding
Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
Task Area A Core Study Operations.Task Area A shall encompass annual follow-up of cohort members, clinical endpoints ascertainment, study coordination activities, maintenance of the database and biosp75N92020D00001 · NHLBI · UNIVERSITY OF WASHINGTON · PI MCCLELLAND, ROBYN LEAGH · 2020 to 2025
$17.2M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00005 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WATSON, KAROL E · 2020 to 2025
$5.1M
The Cardiac Atlas ProjectR01HL121754 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MCCULLOCH, ANDREW D., OMENS, JEFFREY H. · 2014 to 2023
$5.0M
TO EXERCISE OPTION PERIOD ONE (1) FOR TASK AREA A - MESA CORE OPERATIONS, FIELD CENTER.75N92020D00004 · NHLBI · NORTHWESTERN UNIVERSITY · PI SIEGEL, JONATHAN H · 2020 to 2025
$4.5M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00006 · NHLBI · UNIVERSITY OF MINNESOTA · PI PANKOW, JAMES S · 2020 to 2025
$4.4M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00003 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI POST, WENDY S · 2020 to 2025
$3.8M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00007 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BERTONI, ALAIN GERALD · 2020 to 2025
$3.5M
Task Area A shall encompass annual follow-up of cohort members, clinical events investigations, study operations, and data analysis and manuscript writing. If implemented, Task A.1 will provide fundin75N92020D00002 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SHEA, STEVEN J · 2020 to 2025
$3.4M
Cigarette Smoke and Susceptibility to Influenza InfectionR01HL095163 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JASPERS, ILONA, NOAH, TERRY L · 2009 to 2013
Background Left ventricular (LV) subclinical remodeling is associated with adverse outcomes and indicates mechanisms of disease development. Standard metrics such as LV mass and volumes may not capture the full range of remodeling. Purpose To quantify the relationship between LV three-dimensional shape at MRI and incident cardiovascular events over 10 years. Materials and Methods In this retrospective study, 5098 participants from the Multi-Ethnic Study of Atherosclerosis who were free of clinical cardiovascular disease underwent cardiac MRI from 2000 to 2002. LV shape models were automatically generated using a machine learning workflow. Event-specific remodeling signatures were computed using partial least squares regression, and random survival forests were used to determine which features were most associated with incident heart failure (HF), coronary heart disease (CHD), and cardiovascular disease (CVD) events over a 10-year follow-up period. The discrimination improvement of adding LV shape to traditional cardiovascular risk factors, coronary artery calcium scores, and N-terminal pro-brain natriuretic peptide levels was assessed using the index of prediction accuracy and time-dependent area under the receiver operating characteristic curve (AUC). Kaplan-Meier survival curves were used to illustrate the ability of remodeling signatures to predict the end points. Results Overall, 4618 participants had sufficient three-dimensional MRI information to generate patient-specific LV models (mean age, 60.6 years ± 9.9 [SD]; 2540 women). Among these participants, 147 had HF, 317 had CHD, and 455 had CVD events. The addition of LV remodeling signatures to traditional cardiovascular risk factors improved the mean AUC for 10-year survival prediction and achieved better performance than LV mass and volumes; HF (AUC, 0.83 ± 0.01 and 0.81 ± 0.01, respectively;
Indexed as
AtherosclerosisCardiovascular DiseasesCoronary DiseaseHeart FailureFemaleHumansMagnetic Resonance ImagingMiddle AgedPredictive Value of TestsProspective StudiesRetrospective StudiesRisk Factors
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Multi-Ethnic Study of Atherosclerosis: Relationship between Left Ventricular Shape at Cardiac MRI and 10-year Outcomes. · full record | OpenQuestion